These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33783484)

  • 1. Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD - Challenges and Future Directions.
    Dart RJ; Ellul P; Scharl M; Lamb CA
    J Crohns Colitis; 2021 Sep; 15(9):1407-1409. PubMed ID: 33783484
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-Disease Outcome and Response to Therapy.
    Verstockt B; Noor NM; Marigorta UM; Pavlidis P; Deepak P; Ungaro RC;
    J Crohns Colitis; 2021 Sep; 15(9):1431-1442. PubMed ID: 33730756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-What, Why, and How.
    Fiocchi C; Dragoni G; Iliopoulos D; Katsanos K; Ramirez VH; Suzuki K;
    J Crohns Colitis; 2021 Sep; 15(9):1410-1430. PubMed ID: 33733656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-Prediction and Prevention of Inflammatory Bowel Disease.
    Torres J; Halfvarson J; Rodríguez-Lago I; Hedin CRH; Jess T; Dubinsky M; Croitoru K; Colombel JF
    J Crohns Colitis; 2021 Sep; 15(9):1443-1454. PubMed ID: 33730755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 3rd S-ECCO IBD Masterclass, Copenhagen, February 19-20, 2014.
    Zmora O
    Tech Coloproctol; 2014 Aug; 18(8):769-70. PubMed ID: 24962494
    [No Abstract]   [Full Text] [Related]  

  • 6. Precision Medicine in Pediatric Inflammatory Bowel Disease.
    Spencer EA; Dubinsky MC
    Pediatr Clin North Am; 2021 Dec; 68(6):1171-1190. PubMed ID: 34736583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precision medicine in IBD: genes, drugs, bugs and omics.
    Mao R; Chen M
    Nat Rev Gastroenterol Hepatol; 2022 Feb; 19(2):81-82. PubMed ID: 34785787
    [No Abstract]   [Full Text] [Related]  

  • 8. Challenges in IBD Research: Precision Medicine.
    Denson LA; Curran M; McGovern DPB; Koltun WA; Duerr RH; Kim SC; Sartor RB; Sylvester FA; Abraham C; de Zoeten EF; Siegel CA; Burns RM; Dobes AM; Shtraizent N; Honig G; Heller CA; Hurtado-Lorenzo A; Cho JH
    Inflamm Bowel Dis; 2019 May; 25(Suppl 2):S31-S39. PubMed ID: 31095701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IBD 2020: Right therapy, right patient, right time - Choosing wisely: Conclusions.
    Sparrow M
    J Gastroenterol Hepatol; 2021 Apr; 36 Suppl 1():35-36. PubMed ID: 33817856
    [No Abstract]   [Full Text] [Related]  

  • 10. IBD in 2016: Biologicals and biosimilars in IBD - the road to personalized treatment.
    Gecse KB; Lakatos PL
    Nat Rev Gastroenterol Hepatol; 2017 Feb; 14(2):74-76. PubMed ID: 28074074
    [No Abstract]   [Full Text] [Related]  

  • 11. [The 8th Congress of ECCO, 14-16 February 2013. Vienna, Austria].
    Lazebhik L
    Eksp Klin Gastroenterol; 2013; (3):76-7. PubMed ID: 24294776
    [No Abstract]   [Full Text] [Related]  

  • 12. Non-colorectal intestinal tract carcinomas in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (II).
    Egan L; D'Inca R; Jess T; Pellino G; Carbonnel F; Bokemeyer B; Harbord M; Nunes P; Van der Woude J; Selvaggi F; Triantafillidis J
    J Crohns Colitis; 2014 Jan; 8(1):19-30. PubMed ID: 23664498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 4th S-ECCO IBD Masterclass, Barcelona, February 19, 2015.
    Zmora O
    Tech Coloproctol; 2015 Aug; 19(8):495-6. PubMed ID: 26150345
    [No Abstract]   [Full Text] [Related]  

  • 14. NASPGHAN single-topic symposium: discovering the future of pediatric IBD care.
    Crandall WV; Baldassano R; Bousvaros A; Denson LA; Gupta N; Mackner LM
    J Pediatr Gastroenterol Nutr; 2014 Jan; 58(1):130-8. PubMed ID: 24378522
    [No Abstract]   [Full Text] [Related]  

  • 15. How will new and future therapies change our treatment of IBD?
    Zundler S; Neurath MF
    Expert Rev Clin Immunol; 2016; 12(3):233-6. PubMed ID: 26558407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III).
    Magro F; Peyrin-Biroulet L; Sokol H; Aldeger X; Costa A; Higgins PD; Joyce JC; Katsanos KH; Lopez A; de Xaxars TM; Toader E; Beaugerie L
    J Crohns Colitis; 2014 Jan; 8(1):31-44. PubMed ID: 23721759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future therapeutic approaches for inflammatory bowel diseases.
    Plevy SE; Targan SR
    Gastroenterology; 2011 May; 140(6):1838-46. PubMed ID: 21530750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Diagnosis, Early Stratification, and Early Intervention to Deliver Precision Medicine in IBD.
    Noor NM; Sousa P; Paul S; Roblin X
    Inflamm Bowel Dis; 2022 Aug; 28(8):1254-1264. PubMed ID: 34480558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of opportunistic infections in patients with inflammatory bowel disease and implications of the ECCO consensus in Belgium.
    Rahier JF; Moreels T; De Munter P; D'Haens G
    Acta Gastroenterol Belg; 2010; 73(1):41-5. PubMed ID: 20458849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy.
    Hedin CRH; Vavricka SR; Stagg AJ; Schoepfer A; Raine T; Puig L; Pleyer U; Navarini A; van der Meulen-de Jong AE; Maul J; Katsanos K; Kagramanova A; Greuter T; González-Lama Y; van Gaalen F; Ellul P; Burisch J; Bettenworth D; Becker MD; Bamias G; Rieder F
    J Crohns Colitis; 2019 Apr; 13(5):541-554. PubMed ID: 30445584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.